Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 11, 2005Journal of Biological ChemistryOpen Access

Activation and Inhibition of Anaplastic Lymphoma Kinase Receptor Tyrosine Kinase by Monoclonal Antibodies and Absence of Agonist Activity of Pleiotrophin

View Full Paper
Ask AI
Bookmark
Share

Authors

CMChristel Moog‐LutzCentre National de la Recherche ScientifiqueJDJoffrey L. DegoutinAix-Marseille UniversitéJGJean Y. GouziHarvard University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Moog‐Lutz et al. (2005) studied this question.

synapsesocial.com/papers/6a778315df493903fd1efe06https://doi.org/10.1074/jbc.m501972200
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Preferential transformation of human neuronal cells by human adenoviruses and the origin of HEK 293 cells2002 · 803 citations
  2. 2Agonistic monoclonal antibodies against the Met receptor dissect the biological responses to HGF1998 · 197 citations
  3. 3Targeted disruption of the mouse <i>Stat3</i> gene leads to early embryonic lethality1997 · 1,346 citations
  4. 4Epitope mapping and functional studies with three monoclonal antibodies to the C‐KIT receptor tyrosine kinase, YB5.B8, 17F11, and SR‐11994 · 30 citations